Document is current
Any future updates will be listed below
-
Authors
Kast, Karin
John, Esther M.
Hopper, John L.
Andrieu, Nadine
Noguès, Catherine
Mouret-Fourme, Emmanuelle
Lasset, Christine
Fricker, Jean-Pierre
Berthet, Pascaline
Mari, Véronique
Salle, Lucie
Schmidt, Marjanka K.
Ausems, Margreet G. E. M.
Garcia, Encarnacion B. Gomez
van de Beek, Irma
Wevers, Marijke R.
Evans, D. Gareth
Tischkowitz, Marc
Lalloo, Fiona
Cook, Jackie
Izatt, Louise
Tripathi, Vishakha
Snape, Katie
Musgrave, Hannah
Sharif, Saba
Murray, Jennie
,
Colonna, Sarah V.
Andrulis, Irene L.
Daly, Mary B.
Southey, Melissa C.
de la Hoya, Miguel
Osorio, Ana
Foretova, Lenka
Berkova, Dita
Gerdes, Anne-Marie
Olah, Edith
Jakubowska, Anna
Singer, Christian F.
Tan, Yen
Augustinsson, Annelie
Rantala, Johanna
Simard, Jacques
Schmutzler, Rita K.
Milne, Roger L.
Phillips, Kelly-Anne
Terry, Mary Beth
Goldgar, David
van Leeuwen, Flora E.
Mooij, Thea M.
Antoniou, Antonis C.
Easton, Douglas F.
Rookus, Matti A.
Engel, Christoph
-
Funding
Funding for this research was provided by:
German Cancer Aid (110837, 70114178)
Federal Ministry of Education and Research (01GY1901)
USA National Cancer Institute (U01 CA164920)
Cancer Australia (809195, 1100868)
Australian National Breast Cancer Foundation (IF 17 kConFab)
National Health and Medical Research Council (454508, 288704, 145684)
the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and the Cancer Foundation of Western Australia
Fondation de France and the Ligue Nationale Contre le Cancer
INCa as part of the European program ERA-NET on Translational Cancer Research (TRANSCAN-JTC2012, n°2014-008)
Dutch Cancer Society (NKI1998-1854, NKI2004-3088, NKI2007-3756, NKI 12535)
The Netherlands Organisation of Scientific Research (NWO 91109024)
The Pink Ribbon (110005, 2014-187.WO76)
BBMRI (NWO 184.021.007/CP46)
Transcan (JTC 2012 Cancer 12-054)
Cancer Research UK (PRCPJT-Nov21\100004, C1287/A23382, C1287/A26886)
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
MH CZ - DRO (MMCI, 00209805)
FEDER funds and the Spanish Network on Rare Diseases (FIS PI19/00640)
Canadian Institutes of Health Research for the “CIHR Team in Familial Risks of Breast Cancer” program and by the Canadian Breast Cancer Research Alliance (#019511)
NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 16 December 2022
Accepted: 10 June 2023
First Online: 20 June 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the local institutional research committee and with the 1064 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: The authors declare that they have no competing interests.
